Abstract
Objective of the present study is aimed to determine costs of rheumatoid arthritis (RA) based on reimbursement agencies perspective [Social Security Institution(SSI)] in Turkey. The international clinical guidelines for RA are followed for analysing the direct costs. Data were collected from hospital bills, social security institution price lists, and Ministry of Health drug price list. Direct costs of RA patients were estimated as €2,669.14 patient/year. Outpatient costs were found to be €240.40. Routine tests during the year were calculated as €98.85. Ten percent of patients are hospitalized per year, and 0.62% of these patients received arthroplasty and/or other interventions. The cost during hospital stay was €87.76. €2,238 was determined as being paid per year for medication alone (including anti-TNF) and €4 is spent on auxiliary materials annually. Our data show a remarkable economic impact of RA over society. We hope that the cost of RA studies will help package price practices for reimbursement agencies.
Similar content being viewed by others
References
Silman AJ, Pearson JE (2002) Epidemiology and genetics of rheumatoid arthritis. Arthritis Res 4(Suppl 3):S265–S272. doi:10.1186/ar578
Kacar C, Gilgil E, Tuncer T, Bütün B, Urhan S, Arıkan V et al (2005) Prevalence of rheumatoid arthritis in Antalya, Turkey. Clin Rheumatol 24(3):212–214. doi:10.1007/s10067-004-1006-4
Turkish Republic Ministry of Health Refik Saydam Hygiene Center Presidency School of Public Health, “National Burden of Disease and Cost Effectiveness Study” 2005
Fautrel B, Guillemin F (2002) Cost of illness studies in rheumatic diseases. Curr Opin Rheumatol 14:121–126. doi:10.1097/00002281-200203000-00008
Kobelt G, Eberhardt K, Geborek P (2004) TNF inhibitors in the treatment of rheumatoid arthritis in clinical practice: costs and outcomes in a follow up study of patients with RA treated with etanercept or infliximab in southern Sweden. Ann Rheum Dis 63:4–10. doi:10.1136/ard.2003.010629
Lambert CM (2001) Medical therapy for rheumatoid arthritis-value for money. Rheumatology 40:961–964. doi:10.1093/rheumatology/40.9.961
Cooper NC (2000) Economic burden of rheumatoid arthritis: a systematic review. Rheumatology 39:28–33. doi:10.1093/rheumatology/39.1.28
Brennan A, Bansback N, Reynolds A, Conway P (2004) Modelling the cost-effectiveness of etanercept in adults with rheumatoid arthritis in the UK. Rheumatology 43:62–72. doi:10.1093/rheumatology/keg451
Péntek M, Kobelt G, Czirják L, Szekanecz Z, Poor G, Rojkovich B et al (2007) Costs of rheumatoid arthritis in Hungary. J Rheumatol 34:1437
Liang MH, Larson M, Thompson M, Eaton H, McNamara E, Katz R et al (1984) Costs and outcomes in rheumatoid arthritis and osteoarthritis. Arthritis Rheum 27:522–529. doi:10.1002/art.1780270507
American College of Rheumatology (2002) Guidelines for the management of rheumatoid arthritis. Arthritis Rheum 46(2):328–346. doi:10.1002/art.10148
Combe B, Landewe R, Lukas C, Bolosiu HD, Breedveld F, Dougados M (2007) EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis 66(1):34–45. doi:10.1136/ard.2005.044354
Maetzel A, Tugwell P, Boers M, Guillemin F, Coyle D, Drummond M et al (2003) Economic evaluation of programs or interventions in the management of rheumatoid arthritis: defining a consensus-based reference case. J Rheumatol 30:891–896
Gabriel S, Drummond M, Maetzel A, Boers M, Coyle D, Welch V et al (2003) OMERACT 6 Economics Working Group report: a proposal for a reference case for economic evaluation in rheumatoid arthritis. J Rheumatol 30:886–890
Bodur H, Ataman S, Akbulut L, Evcik D, Kavuncu V, Kaya T et al (2008) Characteristics and medical management of patients with rheumatoid arthritis and ankylosing spondylitis. Clin Rheumatol 27:1119–1125. doi:10.1007/s10067-008-0877-1
T.C. Sağlık Bakanlığı İlaç Eczacılık Genel Müdürlüğü Temel İlaç Fiyat listesi
T.C. Sosyal Güvenlik Kurumu Sağlık Uygulama Tebliği
Cowley P, Bodabilla L, Musgrove P, Saxenian H (1994) Content and Financing of an essential national package of health services, global assessments in the health sector, World Health Organization, pp 171–181
Lubeck DP, Spitz PW, Fries JF, Wolfe F, Mitchell DM, Roth SH (1986) Multicenter study of annual health service utilization and cost in rheumatoid arthritis. Arthritis Rheum 29:488–493. doi:10.1002/art.1780290405
Clarke AE, Zowall H, Levinton C, Assimakopoulos H, Sibley JT, Haga M et al (1997) Direct and indirect medical costs incurred by Canadian patients with rheumatoid arthritis: a 12 year study. J Rheumatol 24:1051–1060
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Malhan, S., Akbulut, L.A., Bodur, H. et al. Annual costs of rheumatoid arthritis in Turkey. Rheumatol Int 30, 637–641 (2010). https://doi.org/10.1007/s00296-009-1040-2
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00296-009-1040-2